title: Dendritic cell-based graft tolerance.
abstract: It has recently been demonstrated that mouse and human dendritic cells (DCs) can produce IL-2 after activation. However the role of the IL2/IL2R pathway in DC functions has not yet been fully elucidated. The results presented in this study provide several new insights into the role of this pathway in DCs. We report that stimulation of human monocyte-derived DCs with LPS strongly upregulated CD25 (α chain of the IL2R) expression. In additon, by using a humanized monoclonal antibody against CD25, we demonstrated that the IL2 signalling in DC upregulated both IL-12 and γIFN production but decreased IL10 synthesis. We also found that LPS-matured DCs produced IL2. Taken together, these results suggest that IL-2 actively contributes to the DC activation through an autocrine pathway. Furthermore, our results indicate that the IL2 pathway in DC is involved in the development of T-helper priming ability and in the upregulation of surface markers characteristic of a "mature" phenotype. This study therefore provide new molecular clues regarding the split between these two phenomena and unravel new mechanisms of action of anti-CD25 monoclonal antibodies that may contribute to their action in several human immunological disorders such as autoimmune diseases and acute allograft rejection.
authors.affiliation: Laboratory of Environnemental Immuno-Microbiology and Cancerogenesis (IMEC Unit), Department of Biology, Faculty of Sciences of Bizerte, Zarzouna 7021, Tunisia.
authors.forename: Mnasria
authors.initials: M
authors.lastname: Kaouther
authors.forename: Oueslati
authors.initials: O
authors.lastname: Ridha
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: Annu Rev Immunol. 2003;21:685-711
references.pmid: 12615891
references.citation: Curr Opin Immunol. 2004 Feb;16(1):21-5
references.pmid: 14734106
references.citation: Int Immunol. 1998 Feb;10(2):237-40
references.pmid: 9533452
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8705-8
references.pmid: 15161974
references.citation: Nat Med. 1999 Apr;5(4):405-11
references.pmid: 10202929
references.citation: J Immunol. 1995 May 15;154(10):5071-9
references.pmid: 7730613
references.citation: J Exp Med. 1983 Feb 1;157(2):613-27
references.pmid: 6185614
references.citation: J Exp Med. 2004 Aug 2;200(3):287-95
references.pmid: 15289500
references.citation: Blood. 2005 Jan 15;105(2):697-702
references.pmid: 15353479
references.citation: Annu Rev Immunol. 2000;18:767-811
references.pmid: 10837075
references.citation: Nat Immunol. 2001 Sep;2(9):882-8
references.pmid: 11526406
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6
references.pmid: 16585503
references.citation: Nat Immunol. 2000 Sep;1(3):199-205
references.pmid: 10973276
references.citation: Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):351-8
references.pmid: 11773639
references.citation: N Engl J Med. 1998 Jan 15;338(3):161-5
references.pmid: 9428817